Another meta-analysis was conducted by Wang Y. D. et al. [41], the results of which showed a positive association between serum OPN levels and ovarian cancer (SMD = 2.60, 95% CI 1.88–3.32, p < 0.001). Here, SPP1 is linked to ovarian carcinoma.